Versant Venture Management as of Dec. 31, 2015
Portfolio Holdings for Versant Venture Management
Versant Venture Management holds 7 positions in its portfolio as reported in the December 2015 quarterly 13F filing
| Company (Ticker) | Portfolio Weight | Valued At | Change in Shares | Share Count | Share Price |
|---|---|---|---|---|---|
| Glaukos (GKOS) | 45.4 | $78M | 3.1M | 24.74 | |
| Five Prime Therapeutics | 26.5 | $45M | 1.1M | 41.50 | |
| Ocular Therapeutix (OCUL) | 12.2 | $21M | 2.2M | 9.37 | |
| Clovis Oncology | 8.3 | $14M | 407k | 35.00 | |
| Achaogen | 4.3 | $7.4M | 1.3M | 5.74 | |
| Biotie Therapies Corp. ads | 2.3 | $3.9M | 269k | 14.35 | |
| Cymabay Therapeutics | 1.0 | $1.8M | 1.0M | 1.69 |
